| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophys J, November 2002, p. 2726-2732, Vol. 83, No. 5
and
*Department of Chemistry and Biochemistry and the Molecular Biology
Institute, University of California, Los Angeles, California
90095 and
Department of Biochemistry, College of
Medicine, University of Iowa, Iowa City, Iowa 52242 USA
| |
ABSTRACT |
|---|
|
|
|---|
The N-terminal region in actin has been shown to interact with both myosin and troponin (Tn) during the cross-bridge cycle and in regulation. To study the role of this region in regulation, we used yeast actin mutants with increased and decreased numbers of acidic residues. The mutants included D24A/D25A, with Asp24 and Asp25 replaced with alanines; DNEQ, with the substitution of Asp2 and Glu4 with their amide analogs; and 4Ac, with Glu3 and Asp4 inserted in lieu of Ser3. In the in vitro motility assay, using reconstituted regulated thin filaments, the sliding speeds of DNEQ, D24A/D25A, and 4Ac were similar at all pCa values. Thus, Ca2+-sensitivity of the thin filaments and the inhibitory function of TnI appear to be insensitive to changes in charge (±2) at the N-terminus of actin, suggesting little, if any, role of that actin region in regulation. A Ca2+-independent conformational change in that region was detected upon troponin binding to actin-Tm via an increase in the fluorescence of a pyrene probe attached to another yeast actin mutant that we used (Cys1).
| |
INTRODUCTION |
|---|
|
|
|---|
In Ca2+-dependent
regulation of the cross-bridge cycle, a series of direct and allosteric
interactions between actin, tropomyosin (Tm), troponin (Tn), and myosin
mediate the activation of the thin filament (reviewed in Leavis
and Gergely, 1984
; Zot and Potter, 1987
; Farah and Reinach, 1995
;
Tobacman, 1996
). In the three-state model proposed by McKillop and
Geeves (1993)
, Tm moves across F-actin as calcium and myosin bind to,
and induce conformational changes in, the thin filament. In this
scheme, the regulatory complex equilibrates among the
blocked, closed, and open states. Structural studies (Lehman et al., 1994
; Narita et al., 2001
) and
kinetic measurements (McKillop and Geeves, 1993
; Geeves and Lehrer,
1994
) support a repositioning of Tm on the actin filament upon
Ca2+ addition. The recent higher resolution
three-dimensional reconstruction of the thin filament (Lehman et al.,
2001
), that also includes the first mapping of the Tn positions on
actin, is consistent with the main tenets of the McKillop and Geeves'
three-state regulation model.
In the muscle thin filaments, Tn binds to actin-tropomyosin with a
stoichiometry of 1 Tn to 1 Tm to 7 actin subunits (Ebashi et al., 1969
;
Potter and Gergely, 1974
). In the absence of
Ca2+, the Tm-Tn complex inhibits actomyosin
interactions by predominantly occupying the blocked state, sterically
restricting the access of myosin to weak-binding sites on actin
(reviewed in Lehrer and Geeves, 1998
; Squire and Morris, 1998
). In this
mechanism, the inhibitory function of TnI (the inhibitory subunit of
Tn) is maintained through contacts to actin and TnC (the calcium
binding subunit of Tn). Another region of TnI interacts with TnT
(tropomyosin binding subunit of Tn), relaying perhaps conformational
changes to Tm (reviewed in Perry, 1999
). Upon
Ca2+-activation, Tn undergoes conformational
changes that result in a shift of Tm-Tn to the closed state, in which
the myosin weak-binding sites are exposed (Lehman et al., 2001
).
It has been hypothesized that the interaction between TnI and actin is
maintained by electrostatic contacts, and that this mode of interaction
is important in Tn-dependent regulation of actomyosin in the presence
of Tm. The basis for this hypothesis rests with the use of synthetic
peptide analogs of the inhibitory region of TnI, i.e., that part of the
protein which, by itself, inhibits actin-activated myosin ATPase
(Talbot and Hodges, 1981
; Levine et al., 1988
). Van Eyk and Hodges
(1988)
identified lysine and arginine residues on TnI that are
essential for the maximal inhibition of acto-S1 ATPase. However, other
explanations for these results are also possible.
Chemical cross-linking results (Gergely et al., 1988
) and NMR studies
(Levine et al., 1988
) imply a direct interaction between actin
N-terminal acidic residues and TnI. In addition, the recent electron
microscopy-based reconstituted thin actin filament model shows
Tn in close contact with the N-terminal residues 1-4 and 23-27 on
actin (Lehman et al., 2001
). However, the functional importance of
these interactions in the regulation of actomyosin ATPase with fully
reconstituted thin filaments has never been established or even tested.
Questions about Tm and Tn binding sites on actin can also be raised
regarding the Tm-based, cooperative and allosteric model for
thin-filament regulation (Lehrer and Geeves, 1998
). The role of Tn in
this model is that of an allosteric inhibitor of S1 binding to the thin
filament and switching it into an activated form. Clearly, it is
essential to map at a high resolution the Tm and Tn contacts on actin
and determine the importance of the ionic actin-Tn interaction if we
are to understand the molecular basis of the control of muscle contraction.
To this end, we used in this work yeast actin mutants with
Asp24 and Asp25 residues
replaced with alanines (D24A/D25A); with two residues substituted
(Asp2 to asn and
Glu4 to gln), neutralized at the
N-terminus (DNEQ); or with asp and glu in lieu of
Ser3 added to the N-terminus (4Ac) in subdomain 1 of actin (Fig. 1). These mutants have been used previously to assess
the role of actin N-terminal acidic residues in the formation of the
weak and strong binding states with myosin subfragment-1 (Miller et al., 1996
; Wong et al., 1999
). Here, we use them to evaluate the importance of these residues on the ability of Tn, together with Tm, to
regulate the sliding of actin
filaments.
|
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Reagents
Adenosine triphosphate (ATP), dithiothreitol (DTT), phalloidin,
phenylmethylsulfonyl fluoride, dextrose,
2-{[tris(hydroxymethyl)methyl]amino}-1-ethane sulfonic acid
(TES), ethylene glycol-bis(
-aminoethyl
ether)N,N,N',N'-tetraacetic acid (EGTA), Tris-HCl, and
-mercaptoethanol were purchased from Sigma (St. Louis, MO). Yeast extract and tryptone were purchased from Difco (Detroit, MI). DNase I column materials were purchased from
Worthington Biochemical Co. (Lakewood, NJ; DNase I) and Bio-Rad (Hercules, CA; Affigel-10). The fluorescent labels rhodamine phalloidin and N-(1-pyrene)-maleimide were purchased from Molecular
Probes (Eugene, OR).
Preparation of proteins
Actin mutants were expressed in Saccharomyces
cerevisiae yeast strain cultures (described previously in Wertman
et al., 1992
; Cook et al., 1993
; Hansen et al., 2000
) grown at 25°C;
wild-type yeast was purchased from a commercial bakery. Yeast actins
were isolated from their respective strains using the DNase I affinity chromatography as described previously (Cook et al., 1992
). All yeast actins were used within two weeks of purification. The
concentrations of the mutant actins were determined using the Bradford
protein assay, and rabbit actin as a standard. Rabbit actin and myosin were prepared from rabbit skeletal muscle according to the methods of
Spudich and Watt (1971)
and Godfrey and Harrington (1970)
, respectively. Myosin subfragment 1 (S1) was prepared by chymotryptic digestion, according to the method of Weeds and Pope (1977)
. The concentrations of rabbit actin and S1 were determined
spectrophotometrically using extinction coefficients of
280 = 7.5 cm
1 and
292 = 11.5 cm
1 for 1%
protein solutions, respectively. Bovine cardiac Tm and bovine cardiac
Tn were generous gifts from Dr. L. Tobacman (Univ. of Iowa).
Pyrene labeling of M1C/C374A (Cys-1) actin
Following the standard protocol for yeast actin preparation, the
elutant was dialyzed overnight against G-buffer (10 mM Tris-HCl, pH
7.5; 0.2 mM CaCl2, 0.2 mM ATP, pH 7.0) that did
not contain DTT. After determining its actin concentration, actin was
incubated at room temperature for 90 min with a 2.5 molar ratio of
pyrene maleimide (dissolved in dimethyl formamide) and 4 mM
MgCl2. The labeling reaction was quenched with
1.0 mM DTT and spun in a Beckman XT tabletop ultracentrifuge at
140,000 × g for 50 min. The supernatant was discarded; the pellet was resuspended in G-buffer, and then dialyzed overnight. After a final ultracentrifugation, the collected supernatant actin contained the labeled G-actin. The degree of pyrene-modification was determined by comparing the actin concentration (as measured by the Bradford protein assay) with the concentration of
pyrene label, which was determined using the extinction coefficient of
22 mM
1cm
1 at 344 nm.
The degree of labeling was typically ~100%.
Fluorescence measurements with pyrenyl Cys-1 actin
Fluorescence emission spectra for the pyrene-labeled Cys-1 actin
were recorded at 23°C in a SPEX Fluorolog (SPEX Industries Inc.,
Edison, NJ) using an excitation wavelength of 344 nm. The concentrations of actin, Tm, and Tn were 4.0, 2.0, and 1.0 µM, respectively, with equimolar amounts of phalloidin added to stabilize the F-actin (prepolymerized with 3.0 mM MgCl2).
The buffer consisted of 45 mM TES, pH 7.5, 50 mM NaCl, 3 mM
MgCl2, 0.2 mM ATP, 0.2 mM
CaCl2, and 1 mM DTT. EGTA was added to 1.0 mM to
create "
Ca2+" conditions. Troponin
titrations of actin-Tm were carried out ±Ca2+
using the same conditions as above. An excitation wavelength of 344 nm
and an emission wavelength of 394 nm were used, and the concentration
of Tn was increased in increments of ~0.15 µM until the final 1.0 µM concentration was reached.
ATPase regulation of Cys-1 yeast actin
The rates of S1 Mg-ATPase activated by regulated pyrene-labeled
Cys-1 actin in the presence and absence of Ca2+
were obtained as described previously (Gerson et al., 1999
), by using
light scattering to monitor the clearing time of regulated F-acto-S1
solutions. Thin filaments were reconstituted using bovine cardiac Tn,
and bovine cardiac Tm and the pyrene-labeled actin. The concentrations
of actin, Tm, Tn, and S1 were 4.0, 2.0, 1.0, and 1.0 µM,
respectively. Experiments were carried out at 23°C using a Mg-ATP
concentration of 0.1 mM and either 1.0 mM EGTA or 0.2 mM
CaCl2. The time of Mg-ATP hydrolysis was
monitored by measuring the light scattering at 350 nm from the above
solutions in a SPEX Fluorolog.
In vitro motility assays
The motility assays were performed as described previously
(Homsher et al., 1996
). The temperature was maintained at 25°C for
all assays. Heavy meromyosin (HMM) was prepared as described by Kron et
al. (1991)
. To remove ATP-insensitive heads, HMM was centrifuged with
0.15 mg/ml rabbit F-actin in a solution containing 25 mM MOPS, 25 mM
KCl, 1.0 mM MgCl2, 10 mM DTT, and 4.0 mM ATP at
pH 7.4 for 30 min at 130,000 × g. The
supernatant was applied to nitrocellulose-treated coverslips at an HMM
concentration of 0.3 mg/ml. Sliding speeds at various
[Ca2+] were measured as previously described
(Homsher et al., 1992
). Briefly, a solution containing rhodamine
phalloidin-labeled actin filaments (10 nM), together with skeletal Tm
and bovine cardiac Tn, each at a concentration of 0.5 µM, was applied
to the coverslip. After a 1-min incubation period, the unbound
filaments were washed away with the assay buffer at an ionic
strength = 50 mM (25 mM KCl, 1 mM EGTA, 2 mM
MgCl2, 10 mM DTT, and 10 mM imidazole at pH 7.4).
The viscosity of the assay buffer was enhanced with 0.2% methylcellulose. Movement was initiated with the assay buffer containing 1.0 mM ATP and 0.1 µM each of the regulatory proteins, with an oxygen-scavenging system. Quantification of the sliding velocities was carried out with an Expertvision system (Motion Analysis, Santa Rosa, CA). The velocities of individual filaments with
SD of less than half of the average velocity were used for statistical
analysis (Homsher et al., 1992
), and these filaments were considered to
move smoothly in the assay system. The sliding speeds at various pCa
were fitted to a form of the Hill equation (Homsher et al., 1992
),
|
(1) |
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Experimental considerations
The goal of this work was to test the role of the ionic
interactions between Tn and actin subdomain-1 in the regulation of thin
filaments. Although previous biochemical studies have used purified Tn
subunits (and Tm), particularly for mapping their binding sites on
actin, such measurements are open to questions regarding the
physiological significance of information derived from the partially
reconstructed filaments. For example, it is frequently difficult to
reproduce the precise stoichiometry of the actin-Tm-Tn complex
(7:1:1) when working with actin-Tm and TnI only. Indeed, in our
experiments, the binding of TnI to actin-Tm did not saturate at 1:7
molar ratio of TnI:actin (data not shown). In addition, other
investigators have reported on different classes of TnI binding to
actin-Tm (Zhou et al., 2000
), and on experimental difficulties related
to the tendency of TnI to aggregate (Perry, 1999
; Geeves et al., 2000
).
This complicates any attempts to assess the functional role of specific
sites on subdomain 1 of actin in TnI binding in partially reconstituted
thin filaments. Consequently, this study has been confined to
measurements on the fully reconstituted actin-Tm-Tn complexes.
The measurement of TnI binding to actin cannot be done with a fully
reconstituted actin-Tm-Tn system because it does not allow for
release of the unbound TnI into solution. Therefore, the evaluation of
proposed TnI binding to acidic residues in the N-terminal region of
actin (residues 1-4 and 24, 25) is based in this work on testing of
charge deletions or additions on thin filament regulation. If the
proposed electrostatic contacts are indeed important in the blocked
state of the thin filament (Levine et al., 1988
; Van Eyk and Hodges,
1988
; Tripet et al., 1997
; Lehman et al., 2001
), then charge deletion
mutations in subdomain 1 of actin should destabilize this state. This
would lower the barrier for the transition to the closed and open
states (McKillop and Geeves, 1993
) and would thus increase the
Ca2+ sensitivity of the regulated actin. This
prediction provided the experimental framework for testing the role of
acidic residues in subdomain 1 of actin in Tm/Tn-based regulation with
the help of yeast actin mutants.
Yeast actin is 87% identical (in sequence) with muscle actin (Ng and
Abelson, 1980
). It activates myosin ATPase, moves over muscle myosin in
the in vitro motility assay, and displays the same type of regulation
by Tm-Tn as does muscle actin (Gerson et al., 1999
; Korman and
Tobacman, 1999
; Korman et al., 2000
; Morris et al., 2001
). Although
there are some quantitative differences in the rates of polymerization
and nucleotide exchange between yeast and muscle actins (Kim et al.,
1996
; Chen et al., 1995
), neither of these properties was pertinent to
our studies. Gerson et al. (1999)
have previously used yeast actins to
study calcium-dependent regulation in the in vitro motility assays.
This and the acto-S1 ATPase regulation assays of Korman and Tobacman
(1999)
, Korman et al. (2000)
, and Yao and Rubenstein (2001)
established
yeast actin as an attractive system for probing the mechanism of actin regulation.
The choice of regulation assay
Actin regulation by Tm-Tn can be assayed as a function of pCa in
acto-S1 ATPase activity and in vitro motility measurements. In the case
of yeast actin mutants used in this work (DNEQ and D24A/D25A), which
have fewer putative sites for electrostatic interaction with TnI than
the wild-type actin (
=
2), only the latter option is open.
This constraint is due to the low activation of S1 ATPase by the above
mutants (Miller and Reisler, 1995
; Miller et al., 1996
). As documented
in these prior studies, the low acto-S1 ATPase activities were due to
the reduced weak binding of S1 to DNEQ and D24A/D25A mutant actins. In
the in vitro motility assays, methylcellulose (a viscosity-enhancing
agent) compensates for the reduced myosin binding (in the presence of
ATP) to these actin mutants by inhibiting their diffusion away from the
HMM adsorbed to the cover glass. This restores their sliding to that of
wild type actin (Miller and Reisler, 1995
; Miller et al., 1996
; Wong et
al., 1999
; Doyle and Reisler, 2002
), enabling the testing of their
regulation by Tm-Tn. The sliding speeds of actin filaments in such
assays are not tightly coupled to the
Vmax of actomyosin ATPase. For
example, rabbit skeletal
-actin and wild type and 4Ac yeast actin
filaments move at similar speeds in the motility assays despite the
different Vmax values of their
corresponding acto-S1 ATPase activities (Cook et al., 1993
; Miller et
al., 1996
; Doyle and Reisler, 2002
).
pCa Dependence of regulated actin sliding in the in vitro motility assays
The in vitro motility assays were carried out in the presence of methylcellulose and at an ionic strength of 50 mM, i.e., under conditions at which the mutants and wild-type actin slide at similar speeds over myosin. Figure 2, A and B, shows that the D24A/D25A and DNEQ actins, each with a net decrease of two acidic residues, had sliding speeds similar to wild type actin at all pCa values. The pCa50 values of these mutant and wild-type actin pairs were similar to within ±0.1 pCa units. The sliding speeds of the 4Ac mutant, that has a net increase of two acidic residues, were also similar to wild-type actin at all pCa values (Fig. 2 C), as were the pCa50 values (7.0 ± 0.3 and 6.8 ± 0.1, respectively). These results show that the inhibition of filament movement by the Tn-Tm complex in this assay does not appear to be altered by the number of charged residues (±2) in subdomain 1 of actin.
|
Our results do not reveal any significant destabilization of the
blocked state of the regulated thin filament, or changes in the
Ca2+-sensitivity of regulation when using the
DNEQ, D24A/D25A, and 4Ac actins. Thus, charge alteration in the
putative ionic contacts between TnI and actin subdomain 1 does not
affect the overall Tn-regulation of the thin filament. This apparent
tolerance in the regulation of actin to charge density changes is
inconsistent with the previously proposed binding of TnI to the
N-terminal region on actin. Thus, the N-terminal charged residues on
actin play only a small role, if any, in the TnI-mediated inhibition of
actomyosin. For similar reasons, our results also rule out the
possibility that the acidic sites in subdomain 1 could be involved in
the binding of TnT or Tm to the blocked-state actin. Clearly, none of
the above precludes the possibility that other electrostatic contacts
may contribute to the TnI-actin binding. The results of Bing et al.
(1998)
showed that the Tm-based regulation of E93K actin from
Drosophila melanogaster was severely affected by a more
drastic mutational change, i.e., charge reversal.
Pyrene fluorescence of Cys-1-labeled actin
Pyrene maleimide attached to a cysteine residue introduced at the
N-terminus of actin (Cys1) was used for probing
Tn (or Tm) interactions with that region on actin. Previous work has
shown that at this position the pyrene probe is sensitive to S1 binding
and responds differently to the weakly and strongly bound S1 states
(Hansen et al., 2000
). The activation of S1 ATPase activity by the
pyrenyl Cys-1 actin was similar to that by Cys-1 actin, indicating that
the modification did not alter actin function (Hansen et al., 2000
). We
have verified now that pyrenyl Cys-1 actin is fully regulated by
Tm-Tn, yielding an approximately ten-fold
Ca2+-induced activation of acto-S1 ATPase, as
measured by the ratio of Mg-ATPase activities in the presence of 0.2 mM
Ca2+ and 1.0 mM EGTA.
The spectrum of pyrenyl Cys-1 F-actin was unchanged by addition of Tm,
but the fluorescence intensity increased by ~35% with the binding of
Tn to actin-Tm (Fig. 3 A).
Virtually identical fluorescence enhancement was observed in the
presence and absence of Ca2+ (same increase for
both, Fig. 3 A, blue and pink
traces). Tn binding to actin-Tm, but not the
Ca2+ activation of regulated filaments, appears
to induce conformational changes in the N-terminal region of actin.
This suggests that conformational changes at this site are not coupled
to the activation of thin filaments. Such a result was unexpected in
the context of the perceived biding of TnI to the N-terminus of actin
(Perry, 1999
) and its observed shift away from actin upon
Ca2+-binding to Tn (Tao et al., 1990
). To confirm
the specificity of Tn binding, the modified actin-Tm was titrated to
saturation with Tn both in the presence and absence of calcium (Fig.
3 B,
and
, respectively). The fluorescence increases
plateau in both cases at an ~1:7 molar ratio of Tn to actin,
regardless of the presence or absence of Ca2+.
|
It is tempting to speculate that the change in pyrene fluorescence is
related to the improvement of the strong S1-actin binding in the
presence of regulatory proteins, which is also insensitive to changes
in Ca2+ concentration (Korman et al., 2000
). This
improved recruitment of S1 may be connected to the increase in the
isometric force exerted by myosin on regulated compared to unregulated
actin (Homsher et al., 2000
), and may be the result of allosteric
changes induced in F-actin by Tm-Tn, or a direct S1 interaction with
Tm. In the former scenario, the Ca2+-insensitive,
Tn-induced changes in the N-terminus of actin may be related to the
allosteric transitions that improve S1 binding to actin.
In summary, our results show that electrostatic interactions of Tn (and of other components of the regulatory complex) with the acidic residues in the N-terminal region of actin are not essential for the regulation of actomyosin function by Tm-Tn. This negative result is important for ruling out the previously proposed model of TnI interaction with actin and emphasizes the need for mapping the binding sites for regulatory proteins on actin. Finally, the perturbation of the N-terminus of actin by Tm-Tn may be related to the effect these proteins have on the binding of S1 to actin.
| |
ACKNOWLEDGMENTS |
|---|
We thank Larry S. Tobacman (Univ. of Iowa) for his generous gift of bovine cardiac Tm and Tn.
This work was supported by grants from the United States Public Health Service (AR-22031) and the National Science Foundation (MCB 9904599) to E.R. and from the United States Public Health Service (GM-33689) to P.A.R.
| |
FOOTNOTES |
|---|
Address reprint requests to Emil Reisler, Dept. of Chemistry and Biochemistry and the Molecular Biology Institute, Univ. of California, Los Angeles, CA 90095. Tel.: 310-825-2668; Fax: 310-206-7286; E-mail: reisler{at}mbi.ucla.edu.
Submitted March 19, 2002 and accepted for publication July 17, 2002.
| |
REFERENCES |
|---|
|
|
|---|
-actin.
Biochemistry.
35:16566-16572[Medline].
Biophys J, November 2002, p. 2726-2732, Vol. 83, No. 5
© 2002 by the Biophysical Society 0006-3495/02/11/2726/07 $2.00
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |